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With the increasing number of genomes se-
quenced and available in the public domain,
a large number of orphan gene clusters, for
which the encoded natural product is unknown,
have been identified. These orphan gene clus-
ters represent a tremendous source of novel
and possibly bioactive compounds. Here, we
describe a ‘‘genomisotopic approach,’’ which
employs a combination of genomic sequence
analysis and isotope-guided fractionation to
identify unknown compounds synthesized
from orphan gene clusters containing nonribo-
somal peptide synthetases. Analysis of the
Pseudomonas fluorescens Pf-5 genome led to
the identification of an orphan gene cluster pre-
dicted to code for the biosynthesis of a lipopep-
tide natural product. Application of the genomi-
sotopic approach to isolate the product of this
gene cluster resulted in the discovery of orfa-
mide A, founder of a group of bioactive cyclic
lipopeptides.
INTRODUCTION
Orphan (cryptic) gene clusters, containing biosynthetic
loci for which the corresponding metabolite is unknown,
are found in the genomes of many microorganisms. The
products of these biosynthetic loci represent a rich source
of hitherto unexplored and possibly bioactive compounds,
but, to date, only a small fraction of this potential has been
examined. Strategies employed to purify and characterize
the products of orphan gene clusters include heterolo-
gous expression of orphan gene clusters [1, 2], metabolic
profiling coupled with mutagenesis of orphan genes [3, 4],
and assay-guided fractionation [5–7].Chemistry & Biology 14,In this paper, we propose a straightforward genomiso-
topic approach, which combines the power of genomics
and isotope-guided fractionation to isolate the products
of orphan gene clusters containing nonribosomal peptide
synthetases (NRPSs). We demonstrate the power of this
approach with the discovery of a group of cyclic lipopep-
tides (CLPs) produced by the bacterium Pseudomonas
fluorescens Pf-5. This gram-negative bacterium inhabits
the root surfaces (rhizosphere) of many plants and func-
tions as a biological control agent, suppressing plant dis-
eases caused by soil-borne plant pathogens [8, 9]. Strain
Pf-5 produces at least six secondary metabolites: the
antibiotics pyrrolnitrin [8], pyoluteorin [9], and 2,4-diacetyl-
phloroglucinol [10], two siderophores (a pyoverdine and
pyochelin or a related compound), and hydrogen cyanide
[11]. Bioinformatic analyses of the genomic sequence of
Pf-5 [12] identified three orphan, natural product gene
clusters in addition to the known secondary metabolite
gene clusters. One of these orphan gene clusters contains
NRPSs postulated to synthesize a CLP [12], composed of
a fatty acid tail linked to a peptide that is cyclized to form a
lactone ring [13, 14]. CLPs are synthesized by NRPSs via
a thiotemplate mechanism [15–17], and signature se-
quences within the adenylation domains of the NRPSs
are known to specify the amino acid composition of the
peptide chain [17, 18]. Because the amino acid composi-
tion of the product can be predicted from the nucleotide
sequence of NRPSs [18, 19], we explored the hypothesis
that an isotopically labeled amino acid, predicted to be
a precursor from bioinformatic analysis, would be incor-
porated and therefore enable identification of the natural
product. As a proof of principle, we employed the genomi-
sotopic approach in parallel with traditional assay-guided
fractionation to isolate the CLP, termed orfamide A, from
cultures of Pf-5 (Figure 1). Orfamide A is, to our knowl-
edge, the first member of a new subclass of lipopeptides
produced by Pseudomonas spp. and was shown to have
a role in motility of the producing bacterium and to exhibit
antimicrobial activity.53–63, January 2007 ª2007 Elsevier Ltd All rights reserved 53
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Analysis of the Orphan Gene Cluster Encoding
for the Biosynthesis of Orfamide A
The orphan gene cluster includes three largeORFs termed
ofaA, ofaB, and ofaC, whose deduced amino acid se-
quences are similar to NRPSs. The amino acid sequences
most similar to OfaA, OfaB, and OfaC are NRPSs that syn-
thesize CLPs, including arthrofactin (Arf) [15], syringomy-
cin [16], and syringopeptin [17]. Together, OfaA, OfaB,
and OfaC comprise ten modules, each of which contain
a condensation (C), adenylation (A), and thiolation (T) do-
main characteristic of NRPS elongation modules (Fig-
ure 2). A typical initiation module, which lacks a C domain
[20], is not present in OfaA. The lack of a typical initiation
module has been reported in other NRPSs that encode
for the biosynthesis of lipopeptides [15–17]. Each of the
ten C domains in the Ofa NRPS contains the conserved
Figure 1. Chemical Structures of the Orfamides
Orfamides A, 1; B, 2; and C, 3.54 Chemistry & Biology 14, 53–63, January 2007 ª2007 Elseviemotif HHxxxD involved in amide bond formation [21]. No
epimerization (E) domains are found in OfaA, OfaB, or
OfaC, but six of the ten C domains contain conserved
dual C/E sequences in the N-terminal region (see Supple-
mental Data available with this article online), as recently
described for other NRPSs, including those for Arf bio-
synthesis [22]. The modules having these domains were
not strictly associated with D-amino acids in the resulting
peptide, however, suggesting a complexity in the rela-
tionship between the sequence and final product that is
not fully understood. Each C domain is followed by an
A domain, which catalyzes substrate recognition and
activation. Each A domain contains the conserved core
sequences described by Schwarzer et al. [21] (see Sup-
plemental Data). The A domains are followed by T do-
mains, which function in the transport of the activated
amino acid and elongation intermediates between cata-
lytic centers.
The ten T domains in OfaA, OfaB, or OfaC (see Supple-
mental Data) have a highly conserved core sequencemotif
(DHFFE[L/Q]GGHSL[L/S]A), which includes the invariant
serine residue (underlined) involved in binding of the 40-
phosphopantetheine cofactor [21]. This sequence motif
is identical to that found in the T domains of the Arf NRPSs
[15]. Similarly, two distinct sequence motifs are found
downstream of the core motif in the Ofa T domains, as de-
scribed previously in the T domains of the Arf NRPSs [15].
The C-terminal regions of NRPSs typically contain a thio-
esterase domain required for liberation of the peptide from
the enzyme complex. Two thioesterase domains, each
containing the conserved GXSXG sequence motif, were
found in the C terminus of OfaC. Similarly, two thioester-
ase domains are present in the C termini of NRPSs for
the CLPs Arf [15], syringomycin [16], and syringopeptin
[17] in other Pseudomonas species. Therefore, analysis
of the DNA sequences of ofaA, ofaB, and ofaC provided
three lines of evidence that the product synthesized by
the NRPS is a lipopeptide: (1) the predicted amino acid se-
quence is most similar to NRPSs for the biosynthesis of
lipopeptides by other Pseudomonas species; (2) OfaA
lacks a typical initiation module; and (3) two T domains
are present in the C terminus of OfaC.
Bioinformatic analysis of the A domains led to the pre-
diction of their cognate amino acids and, due to the com-
mon colinearity between the sequence of specific A do-
mains in NRPSs and the sequence of amino acids in
the peptide product [15], also allowed prediction of the
amino acid sequence of the resulting peptide (Figure 2).
Alignment of the amino acids of the predicted compound
with known Pseudomonas lipopeptides of the amphisin
and viscosin classes [13, 14, 23] suggested that the or-
phan metabolite is novel, but closely related to the latter
group (Table 1). From these data, together with the
DNA sequence analysis presented above, we deduced
that orfamide A possesses a lipid side chain, most likely
connected to Leu1. Genes with putative roles in fatty
acid biosynthesis were not found in the ofa gene cluster;
thus, the chain length of the lipid side chain could not be
predicted.r Ltd All rights reserved
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The orfamide gene cluster contains three genes (ofaA, ofaB, and ofaC) encoding nonribosomal peptide synthetases (NRPSs). The domain organiza-
tion of the NRPSs (C, condensation domain; A, adenylation domain; T, thiolation domain; Te, thioesterase domain; M, module) and the specific amino
acid predicted from the sequence of each A domain is shown. The assay-guided approach relies on the development of an assay that guides natural
product isolation. For the genomisotopic approach, the organism of interest is grown under culture conditions favorable to the expression of biosyn-
thetic genes. A labeled amino acid predicted to be present in the metabolic product is added to the culture medium, and the label is used to guide
a fractionation scheme for purification of the natural product.Two-Pronged Approach to Isolate the Product
of the Orphan Pathway, Orfamide A
The genomisotopic approach was evaluated in parallel
with a traditional assay-guided approach for isolation of
orfamide A. Because the structure of the predicted orphan
compound resembles CLPs, the assay-guided arm of the
study relied on the surfactant activity of CLPs. Initially, we
identified a defined culture medium (MBDgly) in which
P. fluorescens Pf-5 produced a biosurfactant and ex-
pressed the orfamide biosynthetic gene ofaB, assessed
with RT-PCR (see Supplemental Data).
To optimize the specificity and sensitivity of the genomi-
sotopic-guided approach, an amino acid that is incorpo-
rated exclusively into the cryptic metabolite is preferred.
Four amino acids (Leu, Ile, and Glu/Asp), which are pres-
ent in the predicted structure of orfamide A (Figure 2)
and are absent from the other known Pf-5 metabolites,
were added to MBDgly and evaluated for toxicity to
Pf-5. None diminished growth or biosurfactant productionChemistry & Biology 14,at the intended feeding levels. Because the binding
pockets of the A domains for Glu or Asp showed only
moderate levels of sequence identity (70% and 80%, re-
spectively) to known A domains, the Glu/Asp set was ex-
cluded from further consideration. Of the two remaining
amino acids, Leu was selected over Ile because its pre-
dicted incorporation into orfamide A at four sites was
expected to give a more robust NMR resonance signal.
15N-labeled Leu was selected because its incorporation
can be detected readily by 1H-15N HMBC NMR spectros-
copy due, in part, to the low natural abundance of 15N.
Structure Elucidation of Orfamide A (1)
Both the genomisotopic approach and the assay-guided
approach led to the isolation of orfamide A (1), which was
isolatedasa yellowishglass fromcultures ofP. fluorescens
Pf-5 at a yield of 5.2–8.4 mg/l. The molecular formula of 1
was deduced as C64H114N10O17 by HR ESI-TOF-MS and
NMR data. The 1H NMR spectrum of orfamide A (1)53–63, January 2007 ª2007 Elsevier Ltd All rights reserved 55
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Viscosin L-Leu D-Glu D-allo- Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Ile C-10
Viscosinamide L-Leu D-Gln D-allo- Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Ile C-10
WLIP L-Leu D-Glu D-allo- Thr D-Val D-Leu D-Ser L-Leu D-Ser L-Ile C-10
Massetolide A L-Leu D-Glu D-allo- Thr D-allo- Ile L-Leu D-Ser L-Leu D-Ser L-Ile C-10
Massetolide B L-Leu D-Glu D-allo- Thr D-allo- Ile L-Leu D-Ser L-Leu D-Ser L-Ile C-11
Massetolide C L-Leu D-Glu D-allo- Thr D-allo- Ile L-Leu D-Ser L-Leu D-Ser L-Ile C-12
Massetolide D L-Leu D-Glu D-allo- Thr D-allo- Ile L-Leu D-Ser L-Leu D-Ser L-Leu C-10
Massetolide E L-Leu D-Glu D-allo- Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Val C-10
Massetolide F L-Leu D-Glu D-allo- Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Leu C-10
Massetolide G L-Leu D-Glu D-allo- Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Ile C-11
Massetolide H L-Leu D-Glu D-allo- Thr D-Val L-Leu D-Ser L-Leu D-Ser L-Ile C-12
Pseudophomin A L-Leu D-Glu D-allo- Thr D-Ile D-Leu D-Ser L-Leu D-Ser L-Ile C-10
Pseudophomin B L-Leu D-Glu D-allo- Thr D-Ile D-Leu D-Ser L-Leu D-Ser L-Ile C-12
Predicted peptide (1) Leu Asp/Glu Thr Ile Leu Ser Leu Leu Ser Val ?
Amphisin D-Leu D-Asp D-allo- Thr D-Leu D-Leu D-Ser L-Leu D-Gln L-Leu L-Ile L-Asp C-10
Tensin D-Leu D-Asp D-allo- Thr D-Leu D-Leu D-Ser L-Leu D-Gln L-Leu L-Ile L-Glu C-10
Lokisin D-Leu D-Asp D-allo- Thr D-Leu D-Leu D-Ser L-Leu D-Ser L-Leu L-Ile L-Asp C-10
Pholipeptin D-Leu L-Asp L-Thr D-Leu D-Leu D-Ser D-Leu D-Ser D-Leu L-Ile D-Asp C-10
Arthrofactin D-Leu D-Asp D-Thr D-Leu D-Leu D-Ser L-Leu D-Ser L-Ile L-Ile L-Asp C-10
Amino acid residues shown in bold are conserved between the predicted peptide structure of orfamide A and the known CLPs.exhibited three clusters of resonances typical of peptides:
exchangeable downfield amide signals at d 7.55–9.43;
a proton resonances observed between d 3.89 and 4.35;
and side chain protons at d 0.88–2.34. Additional evidence
for thepeptidic nature of1 includes thepresenceof numer-
ous carbonyl resonances (d 170.9–180.0) in the 13C NMR
spectrum and the presence of peptide bonds, illustrated
by characteristic IR bands at 3300, 1650, and 1540 cm1.
Standard amino acid analysis of the acid hydrolysate of
1 indicated the presence of the proteinogenic amino acids
Thr, Ser, Glx, Val, Leu, and Met in the molar ratio of
1:2:1:1:4:1. Extensive NMR analysis of 1, including
1H-1H-COSY, 1D- and 2D-TOCSY, HSQC-TOCSY, and
HMBC NMR spectra, confirmed the presence of nine of
ten amino acids and revealed that Glx was glutamic acid
(Glu). The Met residue was revised to be a stereoisomer
of Ile, which was not recognized as such by amino acid
analysis due to its nonstandard chiral character. Data in
support for this revision involved NMR and MS/MS data
along with results of the absolute configuration analysis.
The remaining unassigned 14 carbon and 2 oxygen
atoms not accounted for by amino acids consisted of 1
methyl (d 14.3), 1 carbinol methine (d 69.8), 1 carbonyl car-
bon (d 174.9), and 11 aliphatic methylene carbons (d 44.6,
38.5, and 9 3 30.6), suggesting a linear hydroxy-tetrade-56 Chemistry & Biology 14, 53–63, January 2007 ª2007 Elseviercanoic acid. Correlations in the 1H-1H-COSY delineated
a connected spin system for protons at d 2.42 (H2-2
0),
d 4.08 (H-30), and d 1.49 (H2-40). The observed long-range
1H-13C coupling between H2-2
0 and C-10 subsequently
identified the fatty acid fragment as 3-hydroxy myristic
acid (HMA).
Sequencing of the amino acids and the fatty acid in 1
was accomplished by HMBC and ROESY experiments
(see Supplemental Data). Further evidence supporting
this sequence was developed from ESI-MS/MS experi-
ments. Collisionally induced fragmentation of the parent
ion at m/z 1296 (C64H114N10O17+H)
+ gave ions at m/z
1197 (Ser2-Leu4-Leu3-Ser1-Leu2-Ile-Thr-Glu-Leu1-HMA),
m/z 1110 (Leu4-Leu3-Ser1-Leu2-Ile-Thr-Glu-Leu1-HMA),
m/z 884 (Ser1-Leu2-Ile-Thr-Glu-Leu1-HMA), m/z 797
(Leu2-Ile-Thr-Glu-Leu1-HMA), m/z 683 (Ile-Thr-Glu-
Leu1-HMA), andm/z 340 (Leu1-HMA). Additionally, a sec-
ond fragmentation pattern, deriving from initial cleavage




Leu1-HMA), and m/z 552 (Thr[-H2O]-Glu-Leu1-HMA) and
thus provided additional support for the proposed se-
quence in orfamide A (1).Ltd All rights reserved
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of P. fluorescens Pf-5 and an Orfamide-
Deficient Mutant of Pf-5
(A and B) Profiles of (B) wild-type strain Pf-5
and the (A) orfamide-deficient mutant were ob-
tained by LC-MS (overlaid selected mass
ranges). Compounds identified in the panels
are DAP = 2,4-diacetylphloroglucinol with an
m/z = 210–212 and tR = 3.3 min, PN = pyrrolni-
trin with an m/z = 256–258 and tR = 3.6 min,
PL = pyoluteorin with an m/z = 270–272 and
tR = 3.0 min, PC = pyochelin with an m/z =
324–326 and tR = 4.8 and 5.9 min due to the
formation of stereoisomers, and, finally, orfa-
mides with an m/z = 1250–1300 and tR = 28.0,
32.0, 33.8, 34.8, 36.5, and 41.9 min.The configurations of the amino acids in 1 were deter-
mined by chiral GC-MS and Marfey’s analysis. The acid
hydrolysate of 1 was subjected to chiral GC-MS to yield
L-Val, L-Leu, D-Glu, D-Ser, and D-allo-Thr. A modified Mar-
fey’s method was employed to resolve the configuration
of the remaining Ile residue. Analysis of the derivatized or-
famide A hydrolysate in comparisonwith all four stereoiso-
mers of Ile showed it to be of D-allo configuration. The con-
figuration of the hydroxyl group in the lipid side chain was
not determined; however, since all b-hydroxy acids so far
obtained from related lipopeptides possess an S configu-
ration at this center, we assume that the HMA residue in
orfamide A also has a 30S configuration.
Characterization of an Ofa Mutant of Pf-5
To unambiguously determine if the ofa gene cluster coded
for orfamide A biosynthesis, two Ofa mutants, which
were deficient in biosurfactant production, were derived
independently by allelic exchange mutagenesis of ofaA.
Secondary metabolite production by one Ofa mutantChemistry & Biology 14,was evaluated further. Both Pf-5 and the Ofamutant pro-
duced pyoluteorin, pyochelin, pyrrolnitrin, and 2,4-diace-
tylphloroglucinol, but the Ofa mutant did not produce or-
famides A, B, or C or three related compounds, which
were similar to the orfamides in mass range and polarity
and were found in small amounts in the culture superna-
tants (Figure 3). Therefore, ofaA was required for orfamide
production, but it was not required for the production of
other known secondary metabolites. Due to the estab-
lished role of CLPs in swarming motility and biofilm forma-
tion of other Pseudomonas sp. [14, 15, 24], Pf-5 and the
Ofa mutant were compared for these characteristics.
Both Pf-5 and the Ofa mutant attached to polystyrene
surfaces, an important characteristic related to biofilm for-
mation. In contrast, swarming motility of the Ofa mutant
was dramatically reduced from wild-type levels (Figure 4).
Biological Activity of Orfamide A
Pure 1 lysed zoospores produced by the oomycete
causing ‘‘sudden oak death’’ (Phytophthora ramorum),Figure 4. Swarming Motility of P. fluo-
rescens Pf-5 and an Orfamide-Deficient
Mutant of Pf-5
(A) Orfamide-deficient mutant.
(B) Wild-type P. fluorescens Pf-5.53–63, January 2007 ª2007 Elsevier Ltd All rights reserved 57
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nia [25]. Zoospores were rendered immotile upon expo-
sure to orfamide A, and subsequent lysis occurred in
a dose-dependent manner (e.g., within 60 s at 20 mg/ml,
Figure 5). In contrast, orfamide A had no detectable effect
on the growth or morphology of hyphae of Pythium ulti-
mum or Rhizoctonia solani, plant pathogens that are sup-
pressed by Pf-5 and are sensitive to other secondary me-
tabolites produced by this bacterium [8–11]. In antifungal
assays, orfamide A showed moderate activity (minimum
inhibitory concentration [MIC] = 6.25 mg/ml) against an
amphotericin B-resistant strain of Candida albicans, but




In this investigation, we demonstrated the success of the
genomisotopic approach through its application to an or-
phan biosynthetic gene cluster found in the genome of
P. fluorescens Pf-5. This approach led to the isolation of
the same product, orfamide A (1), that was obtained by us-
ing a predicted biological activity and assay-guided frac-
tionation approach. The genomisotopic approach, which
identifies unknown natural products by feeding isotopi-
cally labeled precursors identified through bioinformatic
analysis of nucleotide sequence data, differs from tradi-
tional isotope-feeding experiments, which map out the
biosynthetic units only after the chemical structure of the
natural product is known. The genomisotopic approach
represents a valuable complement to existing genome-
mining strategies based on heterologous expression of
orphan gene clusters, metabolic profiling coupled with
mutagenesis of orphan genes, and assay-guided fraction-
ation. The genomisotopic approach can be used to iden-
tify compounds encoded by large gene clusters, which are
Figure 5. Effect of Orfamide A on the Viability of Zoospores of
the Oomycete Phytophthora ramorum
Zoospores incubated in the presence of increasing concentrations of
orfamide A lysed after decreasing times of exposure. Zoospores
treated with orfamide A at greater than 25 mg/ml lysed in less than
60 s. The experiment was done twice. Error bars show the standard
error of the mean.58 Chemistry & Biology 14, 53–63, January 2007 ª2007 Elseviedifficult to express in their entirety in heterologous hosts,
as well as compounds lacking predictable bioactivity or
physiochemical properties. Because it requires no previ-
ous knowledge of the activity or structure of a compound,
the proposed strategy offers a powerful approach for the
identification of novel compound classes encoded by or-
phan gene clusters. The genomisotopic approachwas uti-
lized to characterize a peptide in this study, but it could be
applied to various other classes of secondarymetabolites,
including terpenes and shikimates, because the essential
precursors to these natural product classes can also be
predicted by using bioinformatics.
Selection of the appropriate amino acid is critical for
success with the genomisotopic approach, and several
selection criteria should be considered. Confidence in
the bioinformatic prediction of the incorporated amino
acid is of obvious importance. Some amino acids are toxic
to certain organisms [26], necessitating the selection of al-
ternative amino acids, a nontoxic precursor, or subtoxic
concentrations. Preferably, the selected amino acid will
be present only in the product of the orphan pathway,
and it will not be incorporated into any other secondary
metabolite produced by the organism. Stability of the
amino acid is another important characteristic, as degra-
dation can result in dispersal of the label to many other
compounds.
Orfamides
The orfamides (1–3) are, to our knowledge, founding
members of a new class of CLPs, characterized by a 3-hy-
droxy dodecanoic or tetradecanoic (myristic) acid con-
nected to the N terminus of a ten amino acid cyclic pep-
tide. The orfamides are distinct from all known CLPs
produced by Pseudomonas spp., which fit into four major
groups, defined by the length and composition of the
peptide chain (ranging from 9 to 25 amino acids) and the
lipid side chain (ranging from 6 to 16 carbons) [14, 13].
Although CLPs composed of 10 amino acids are produced
by Bacillus strains (plipastatin-fengycin group) [27], the
orfamides (1–3) show a different amino acid sequence
and cyclization scheme.
The architecture of the ofa gene cluster follows the thi-
otemplate mechanism and is in full agreement with the
structure of orfamide A (1). Because a mutation in the
NRPS-encoding gene ofaA eliminated production of all
three orfamides by Pf-5, it is clear that all three com-
pounds are products of the same gene cluster. Therefore,
the production of orfamide B (2) can be attributed to a re-
laxed substrate specificity of the A domain responsible for
the activation of L-Ile. Similar relaxed substrate specificity
of the C domain of module 1 could explain the altered fatty
acid present in orfamide C (3). Neither the respective
genes for the biosynthesis of the lipid side chain (e.g., b-
ketoacyl-ACP synthetases or acyl-CoA ligases) nor genes
involved in an acyltransfer of the 3-hydroxy fatty acid moi-
ety (from the corresponding CoA derivative to the first
amino group Leu1) were found up- or downstream of the
orfamide operon. In other CLP-producing bacteria, fatty
acids for the lipid side chain are synthesized or modifiedr Ltd All rights reserved
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biosynthetic gene cluster, as for iturin A biosynthesis by
Bacillus subtilis [28], or are provided by primary metabo-
lism [29, 30]. Like the ofa gene cluster, the large genomic
island containing the syringomycin and syringopeptin
biosynthetic gene cluster of P. syringae lacks genes for
fatty acid biosynthesis [31]. Therefore, the hydroxy fatty
acids composing the lipid side chains of these CLPs
may be produced by primarymetabolism (e.g., type II fatty
acid synthase systems). Because fluorescent pseudomo-
nads accumulate and utilize 3-hydroxyalkanoates as a
carbon and energy source [32], there is support for this
hypothesis.
Biological Significance
Due to their properties as surfactants, CLPs have multiple
effects on the ecology and physiology of Pseudomonas
spp., including facilitating bacterial growth on water-insol-
uble substrates [33] or seed surfaces [34], influencing sur-
face adhesion and swarming motility of bacterial cells [15,
24], and altering biofilm development and stability [24]. Or-
famide A appears to share at least some of these proper-
ties, as its production has a marked effect on swarming
motility of Pf-5 grown on agar surfaces. However, in con-
trast to the CLPs Arf and putisolvin I and II, orfamide A pro-
duction did not have a detectable influence on the adhe-
sion of Pf-5 cells to polystyrene surfaces. The processes
involved in biofilm formation and development are com-
plex, with adhesion being only one of many aspects. Ef-
fects of orfamide A on biofilm formation and other factors
influencing its ecological fitness in soil and on plant sur-
faces are intriguing subjects for future study.
The remarkable structural diversity of CLPs produced
by Pseudomonas spp. is reflected in the varied antibiotic
properties of these compounds, many of which exhibit an-
tifungal, hemolytic, antiviral, phytotoxic, or antibacterial
activities [13, 14]. In this study, orfamide A exhibited zoo-
sporicidal activity, observed as a rapid lysis of zoospores
of the oomycete Phytophthora ramorum. Because zoo-
spores lack a cell wall, they are especially vulnerable to
membrane disruption caused CLPs [35]. Membrane dis-
ruption can result from nonspecific detergent properties
or from the formation of transmembrane pores by CLPs
[13]. As the sole freely motile propagule of the oomycetes,
zoospores represent a critical stage in the infection cycle
of diseases caused by this important group of plant, in-
sect, fish, and animal pathogens. Thus, with the discovery
of the orfamides, we have identified another important
metabolite class that may contribute to the overall protec-
tive effect of P. fluorescens Pf-5 for its plant hosts.
In contrast to the toxicity of orfamide A to zoospores,
the compound did not inhibit mycelial growth of a fungal
or an oomycete plant pathogen in this study. CLPs pro-
duced by other strains of Pseudomonas spp. are known
to inhibit mycelial growth or development of fungal and
oomycete plant pathogens (reviewed in [13]). A CLP re-
lated to massetolide A, which lyses zoospores of several
oomycete pathogens, is also thought to play a critical
role in the biological control of root rot caused by theChemistry & Biology 14,oomycete Pythium ultimum [35]. The antifungal effect of
orfamide A on the amphotericin B-resistant strain of Can-
dida albicansmay be due to the fact that such strains have
qualitative and quantitative alterations in the lipid compo-
sition of their membranes. The antifungal activities of
CLPs can be attributed, at least in part, to their interac-
tions with membranes, and orfamide A possesses the
suitable size, distribution of polar and lipid moieties, and
three-dimensional shape to interact with the altered mem-
brane of the amphotericin B-resistant strains and, conse-
quently, exert a disruptive effect.
SIGNIFICANCE
The genomisotopic approach provides a powerful new
method by which to identify and mine the products of
orphan biosynthetic gene clusters. This approach re-
liesonbioinformatics topredict precursorsof anatural
product from the sequence of the biosynthetic gene
cluster. A suitable 15N or 15N-13C isotope-labeled pre-
cursor is then selected for exogenous feeding of cul-
tures grown under conditions conducive to gene ex-
pression, identified by RT-PCR. Natural products
produced from this precursor can then be tracked
through the isolation process by selective NMR exper-
iments. In the present study, this approach led to the
discovery of orfamide A. Orfamide A is, to our knowl-
edge, the first member of a new subclass of lipopepti-
des produced by Pseudomonas spp., which has in-




Analytical instrumentation and procedures were essentially as previ-
ously published [36] and are provided in the Supplemental Data.
NMR spectra were referenced to the residual solvent signal with reso-
nances at dH/C 3.31/49.0 (d3-MeOH).
15N chemical shifts were exter-
nally referenced to formamide at 112.0 ppm. Solutions of 15 mg sam-
ple/450 ml d4-MeOH were used for
1H-15N HMBC NMR screening of
fractions, if procurable. 1H-15N HMBC experiments were recorded
with the standard Bruker pulse program (bmHMBCnolp, 256 3 1024
data points, 100 scans, spectral width of 350 ppm and 12 ppm in f1
and f2, D1 = 2 s, D6 = 63 ms, D16 = 250 ms).
Bioinformatic Analysis of the NRPSs in the Orfamide
Biosynthetic Gene Cluster
Catalytic domains present in ofaA, ofaB, and ofaC, three genes
predicted to encode NRPSs, were identified by using the web-based
software NRPS-PKS [37], and the specificity prediction of the adenyla-
tion domains was conducted with the web-based software NRPS
predictor [38].
Identification of Culture Conditions Conducive to Expression
of an Orfamide Biosynthetic Gene
Reverse transcriptase PCR was used to identify culture conditions in
which P. fluorescens Pf-5 expressed ofaB. Three replicate cultures
of Pf-5 were grown in Difco Minimal Broth Davis without dextrose
(Becton Dickinson; Sparks, MD) containing 20 mM glycerol (MBDgly)
with shaking (150 rpm) at 20C for 24 hr prior to harvest (OD600 of
1.1). RNAProtect (QIAGEN; Valencia, CA) was added to each culture,
and RNA was extracted by using the RNA/DNA Midi Kit (QIAGEN),53–63, January 2007 ª2007 Elsevier Ltd All rights reserved 59
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DNase I; QIAGEN). Reverse transcription was done by using Super-
Script II (Invitrogen; Carlsbad, CA). Samples processed in parallel with-
out reverse transcriptase were negative controls. cDNA and negative
controls from each replicate culture were subjected to PCR amplifica-
tion by using primers complementary to ofaB (PF1260F and PF1260R;
see Supplemental Data) and Thermalace (Invitrogen) according to the
manufacturer’s directions.
Extraction and Isolation of Orfamide A
with the Assay-Guided Approach
Cultural Conditions
Starter cultures of Pf-5 were grown in 12.5 ml MBDgly in 50 ml Falcon
tubes for 24–48 hr at 21C in a New Brunswick Scientific C25KC incu-
bator shaker at 150 rpm. Six 2800ml Fernbach flasks containing 1.25 L
MBDgly were inoculated with 1 ml starter culture. Cultures were incu-
bated for 48 hr at 21C with shaking at 150 rpm in darkness.
Biosurfactant Assay
A modification of the droplet collapse assay [24] was used to test the
surfactant activity of bacterial cultures or fractions from solid-phase
extraction, which were dried, weighed, and resuspended in sterile, de-
ionized water to a concentration of 1 mg/ml. A 15 ml drop of test mate-
rial was placed on parafilm (Pechiney Plastic Packaging; Neenah, WI).
The flattening of droplets, which also was visualized as an increase in
the diameter of the droplet, was observed over 5 min. The relative
amount of surfactant activity was estimated with a dilution endpoint
method. Controls for each assay consisted of water, noninoculated
culture media, and cultures of a gacA mutant of Pf-5 (JL4577) [11],
which did not produce detectable surfactant activity (data not shown).
Extraction and Isolation
Cell and supernatant fractions of the cultures were separated by cen-
trifugation in a Jouan CR412 centrifuge at 27003 g for 10 min at room
temperature. Portions (0.5 liter) of the supernatant were extracted
three times with 0.5 liter ethyl acetate to yield 180.0 mg crude extracel-
lular extract. Cells (7.7 g wet wt) were washed twice with water, resus-
pended in acetone, and sonicated for 1 min. Unbroken cells and cell
fragments were removed by centrifugation at 2700 3 g for 10 min at
room temperature, and the resulting supernatant was dried down by
rotary evaporation to give 142.5 mg crude cellular extract. The EtOAc
phase of the extracellular extract was active (at 1:40 dilution) in the
droplet collapse assay. Thus, the extracellular crude extract was fur-
ther fractionated by SPE (Phenomenex Strata C18-E, 2 g) by using
stepwise gradient elution with H2O-MeOH (50:50) to 100% MeOH,
yielding three fractions. Fraction C (109.0 mg), which eluted with
100% MeOH, was found to be most active in the droplet collapse as-
say (1:75 dilution) and was therefore further chromatographed on SPE
(Phenomenex Strata C18-E, 2 g) by using gradient elution from H2O-
MeOH (60:40) to 100%MeOH. The most bioactive fraction (1:75), elut-
ing with H2O-MeOH (10:90), yielded 62.9 mg pure orfamide A (1).
Extraction and Isolation of Orfamide A
with the Genomisotopic Approach
Evaluation of Precursor Toxicity
Pf-5 was cultured in 5 ml MBDgly at 27C with agitation at 200 rpm for
48 hr. L-amino acids were added to brothmedia at a final concentration
of 0.37 mM, which was slightly higher than the intended dosage to be
used in the 15N feeding studies (0.32 mM). The growth rate of Pf-5 was
monitored as an increase in optical density at 600 nm in triplicate cul-
tures. Surfactant activity was assessed with the droplet collapse as-
say. This experiment was repeated three times.
Culture Conditions
Feeding studies with the isotopically labeled precursor 15N-L-leucine
(98%, spectra stable isotopes) were performed under the same culture
conditions as described above, except on a 6 liter scale. 15N-L-leucine
(41.7mg/l = 0.32mM)was added in dH2O 13 hr after inoculation, which
represented the early stage of the exponential phase (12–20 hr).60 Chemistry & Biology 14, 53–63, January 2007 ª2007 ElsevExtraction and Isolation
Cell and supernatant fractions were worked up as described above
and resulted in 53.0 mg crude cell extract and 201.4 mg crude EtOAc
solubles from the culture supernatant. The occurrence of several cor-
relations around 4 ppm on the 1H NMR scale and around 110 ppm on
the 15N NMR scale in the 1H-15N HMBC spectra of the latter extract in-
dicated a 2J long-range coupling between peptidic-bonded nitrogens
of amino acids to their corresponding a protons (N-C-H) and was
therefore of further interest. This material was subfractionated by
SPE (Phenomenex Strata C18-E, 2 g) by using stepwise gradient elu-
tion from H2O-MeOH (50:50) to 100% MeOH to give three fractions,
A–C. Fraction C (81.6 mg), eluting with 100% MeOH, showed strong
2J correlations at about 100 ppm in the 1H-15N HMBC spectrum as
well as several correlations between amide-bonded nitrogens of
amino acids around 100 ppm on the 15N scale and their corresponding
b protons at 1.5–2.1 ppm on the 1H NMR scale (3J, N-C-C-H). Purifica-
tion of this fraction by RP-HPLC by using a linear gradient of 50:50–
90:10 CH3CN-H2O (0.05% TFA) over a period of 30 min, followed by
isocratic elution at 90:10 for an additional 30min (Phenomenex Synergi
Fusion-RP 80, 2503 10 mm, 4 mm in combination with a Phenomenex
SecurityGuard Fusion-RP 103 10 mm precolumn; 2 ml/min flow rate;
UVmonitoring at 210 nm), yielded pure orfamide A (1, 31.2 mg, fraction
C4, tR = 45.1 min), orfamide B (2, 3.3 mg, fraction C3, tR = 41.3 min),
and orfamide C (3, 0.3 mg, fraction C1, tR = 37.9 min). In the
1H-15N
HMBC spectra of the pure compounds, orfamides A (1) and B (2)
showed 2J and 3J couplings, respectively, in addition to one-bond cor-
relations between peptidic nitrogens and their respective protons. No
correlations in the 1H-15N HMBC spectra were observed for orfamide
C (3), most likely due to the low concentration of this sample. Fraction
C2 (2.6 mg, tR = 39.8 min) also showed
1J, 2J, and 3J correlations by
1H-15N HMBC. These were attributed to the presence of a mixture of
at least two or three orfamide-related lipopeptides in this fraction.
Orfamide A, 1
Yellowish glass; ½a26D = +3.8 (c 0.5 MeOH); UV(MeOH) lmax 208 nm
(3 14,400); HR ESI-TOF-MS [M+H]+ m/z 1295.8494 (calc. for
C64H115N10O17, 1295.8442, D +4.0 ppm). All data were determined
with unlabeled orfamide A, which, prior to analysis, was repurified by
RP-HPLC by using the same HPLC conditions as described above.
Absolute Stereochemistry of the Peptide Portion of 1
Unlabeled orfamide (1.3 mg) was dissolved in 1 ml 6N HCl and was hy-
drolyzed in a sealed vial at 100C for 16 hr. The solvent was removed
by using a stream of dry N2, acetyl chloride (150 mM) in 2-propanol
(500 ml) was added, and the solution was heated at 100C for 45 min
to give the isopropyl esters of the various amino acids. After evapora-
tion in a stream of N2, the residue was treated with pentafluoropro-
pionic anhydride (300 ml) in CH2Cl2 (600 ml) at 100
C for 15 min. Excess
reagents were again removed by evaporation under a stream of nitro-
gen, and the resulting mixture of isopropyl esters of N-(pentafluoro-
propyl)-amino acids was dissolved in CH2Cl2 (1 ml) and immediately
analyzed by chiral capillary GC-MS by using an Alltech Chirasil Val col-
umn (25 m 3 0.25 mm; 0.16 mm; program rate: column temperature
held at 70C for 10 min, then 70C–100C at 2C/min, held at 100C
for 10 min, then 100C–200C at 15C/min, held at 200C for an addi-
tional 10 min; flow: 0.6 ml/min; inj. temp. 250C). Helium was used as
the carrier gas.
Standards were prepared and analyzed as described above by us-
ing pure amino acids (0.4 mg). Each peak in the chromatographic trace
was identified by comparing its retention time with that of the corre-
sponding amino acid standard and by coinjection. Retention times
(tr, min) of derivatized residues in the hydrolysate of 1 matched those
of L-Val (10.94), D-allo-Thr (18.09), D-Ser (18.55), L-Leu (20.78), and
D-Glu (39.22) (see Supplemental Data). However, because the reten-
tion times for D-Ile and D-allo-Ile standards were identical (13.77), ste-
reochemical analysis of this residue in 1was precluded by thismethod.
Chiral HPLC analysis of the underivatized hydrolysate of 1 with a Phe-
nomenex Chirex 3126 phase (4.6 3 250; 2 mM CuSO4/MeCN [95:5],ier Ltd All rights reserved
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D-allo-Ile (49.9 min), but did not match the retention time of the stan-
dards (D-Ile, 46.7 min; D-allo-Ile, 43.6 min). Coinjection of the D-Ile or
D-allo-Ile showed in both cases an enhancement of the Ile peak of
the hydrolysate. In general, coinjections were also accompanied by
strong shifts in retention time, suggesting possible saturation of the
chiral selector ligand (D-penicillamine) or disturbance of the ligand ex-
change by the complex mixture of hydrolysis components. Therefore,
Marfey’s method [39] and its modifications [40–42] were utilized to de-
termine the configuration of the Ile residue in 1. Usually, Marfey’s is un-
able to reliably resolve Ile and allo-Ile [41, 42]. However, it was recently
shown that thismethod can discriminate between these stereoisomers
when 1-fluoro-2,4-dinitrophenyl-5-D-leucine amide (D-FDLA) instead
of 1-fluoro-2,4-dinitrophenyl-5-alanine amide (L-FDAA) is used as a de-
rivatizing agent and subsequent RP-HPLC analysis of the resulting de-
rivative is performed (Dtr = 0.2 min) [43], or when L-FDAA derivatives
and a chiral stationary phase HPLC (Dtr = 0.8 min) are used [44, 45].
Consequently, 1.0 mg of 1 was hydrolyzed as described above and
evaporated under N2. To the residue was added 1 M NaHCO3
(200 ml) and 1% L-FDAA in acetone (100 ml), and the solution was
heated at 80C for 40 min, cooled to room temperature, and neutral-
ized with 2 N HCl (100 ml) and then diluted with CH3CN (100 ml). Chiral
HPLC analysis of a 5 ml aliquot through two different chiral columns in
series (Daicel Chiralpak AD-H 4.6 3 250 column, followed by a Daicel
Chiracel OD 4.6 3 250 column) with a linear gradient of 5%–25% iso-
propanol (0.05%TFA) in hexanes over 60min at 1ml/min (UV detection
at 340 nm) cleanly separated D-allo-Ile (38.3 min) and D-Ile (41.1 min).
Coinjection of the hydrolysate with the two standards unequivocally
established this residue as D-allo-Ile.
15N Incorporation Rate
Isotope enrichments in the leucine residues of 1 were calculated from
the isotope cluster of the sodium adduct of the molecular ion from
HR-ESI-TOF MS. Results were processed as previously described
[46] to give 91.6 mole-percent unlabeled and 8.4 mole-percent singly
15N-labeled species. No species with more than one heavy isotope
was present. This result was confirmed by IRMS analysis in which
a level of 8.34% of 15N enrichment was determined.
Allelic Exchange Mutagenesis of ofaA to Generate
an Ofa Mutant of P. fluorescens Pf-5
A 1.7 kb PCR product containing 50 and 30 truncations of the orfamide
biosynthetic gene ofaA, obtained with primers 1801_50ENTR and
1801_30ENTR, respectively (see Supplemental Data), was cloned
into the pENTR/D-TOPO vector (Invitrogen) and integrated into the
destination vector, pLVC-D [47], by using the clonase protocol de-
scribed by Invitrogen. The resultant plasmid (pLVC-D containing 1.7
kb of ofaA) was introduced into the mobilizing strain E. coli S17.1
[48] by transformation, and was then transferred from S17.1 to Pf-5
via conjugation, selecting for tetracycline resistance (200 mg/ml) con-
ferred by the plasmid. Because pLVC-D is a suicide plasmid in Pseu-
domonas spp., tetracycline-resistant colonies of Pf-5 were expected
to have undergone a single-crossover event between the DNA cloned
in pLVC-D and the corresponding sequence in the Pf-5 chromosome.
Gene disruption and plasmid insertion were confirmed by using PCR
with primers specific to the pLVCD vector (LattB2 and UattB1) and ge-
nomic DNA sequences up- and downstream from the targeted genes
(primers 50mkr1801 and 30mkr2, respectively). Two derivatives of Pf-5
with the expected insertion in ofaA were tested for surfactant activity,
and both were deficient. One of the two mutants (termed Ofa) was
characterized further, as described below.
Characterization of the Ofa Mutant
Secondary Metabolite Production
To determine if the Ofa mutant was deficient in orfamide production,
both Pf-5 and the Ofa mutant were grown on a 1 liter scale under the
conditions described above. Supernatants were acidified with HCl to
pH 2 prior to extraction with EtOAc. The EtOAc-soluble parts of theChemistry & Biology 14,crude extracellular extracts (mutant, 40.3 mg; wild-type, 43.3 mg)
were dissolved in MeOH (5 mg/ml) and profiled (Inj. volume 10 ml) by
using the following gradient: linear gradient from 50:50:0.1 to
90:10:0.1 (CH3CN/H2O/TFA) in 30 min, isocratic elution at 90:10:0.1
for 10 min, followed by a linear gradient from 90:10:0.1 CH3CN/H2O/
TFA to 100:0.1 CH3CN/TFA in 20 min (Waters Symmetry C18, 250 3
4.6 mm, 5 mm; 1.0 ml/min flow rate; TIC and PDA monitoring).
Production of pyoluteorin, pyrrolnitrin, and 2,4-diacetylphlorogluci-
nol by Pf-5 and the Ofa mutant was assessed by using published
methods [49]. Briefly, the strains were grown in Difco nutrient broth
(Becton Dickinson) containing 1% (w/v) glycerol at 20C with shaking
(200 rpm) for 48 hr. Pyrrolnitrin was extracted from the cell pellet by us-
ing acetone, and pyoluteorin and 2,4-diacetylphloroglucinol were ex-
tracted from the acidified supernatant (pH 2.0) by using ethyl acetate.
Extracts were taken to dryness, dissolved in methanol, and spotted
onto a silica gel 60 TLC plate containing a fluorophore (F254) (EM Sci-
ence; Gibbstown, NJ). Plates were developed in CHCl3:MeOH (9:1),
dried, and observed under UV light (254 nm). Rf values of UV-absorb-
ing spots were compared to those of authentic standards for each of
the three compounds.
Cell Adhesion
Pf-5 and the Ofa mutant were grown overnight in King’s Medium B
broth (KMB) [50], and 1 ml of the overnight culture was inoculated
into 100 ml KMB contained in each of three wells of a polystyrene 96-
well plate (Falcon U-bottom, non-tissue culture treated) (BD Biosci-
ences; San Jose, CA). Plates were incubated for 24 and 48 hr at
room temperature and were rinsed twice with water to remove nonad-
hering cells, and 200 ml 0.1% (w/v) crystal violet was added to each
well. After incubation for 15 min at room temperature, the crystal violet
was removed from wells and the plates were rinsed twice with water.
Plates were examined for crystal violet-stained rings of adhering bac-
terial cells. Crystal violet retention was quantified by adding 200 ml
95% ethanol to wells and reading the absorbance at 595 nm. The
experiment was done twice.
Swarming Motility
Themethod of Kuiper et al. [24] was used to evaluate swarmingmotility
on solidified media. Pf-5 and the Ofa mutant were cultured overnight
in KMB at 27C. A 5 ml sample of the culture medium was spotted onto
the center of the surface of five replicate plates containing 20-fold di-
luted KMB solidified with 0.3% (w/v) Bacto-Agar (Becton Dickinson).
Plates were incubated at 27C. The experiment was done twice.
Biological Activity of Orfamide A
Antifungal Assays
Wild-type and amphotericin B-resistant strains of Candida albicans
were grown overnight in 30C in RPMI 1640 media (Invitrogen). A he-
macytometer was used to make a cell suspension of each strain at
a concentration of 1 3 104 cells/ml. The indicator Alamar Blue 1003
(TREK Diagnostic Systems) was added to the cell suspension; subse-
quently, cells were added to the microtiter plates. Test materials were
added, serially diluted (2-fold), and incubated for 12–15 hr at 37C. The
viability of the fungal strains was quantified using the dye Alamar Blue
to monitor the reductive environment of living cells. As a positive con-
trol, amphotericin B (0.5 mg/ml) was included; the solvent DMSO
served as a negative control.
The plant pathogens Pythium ultimum isolate N1 and Rhizoctonia
solani AG4 were grown on Potato Dextrose Agar (Becton Dickinson)
for 48 hr. Agar plugs were removed from colony margins and were
placed in the center of petri dishes containing either 25% potato dex-
trose agar for R. solani or simply 2% agar for P. ultimum. Orfamide A
(100 mg) was dissolved in 10 ml methanol and placed on a 5 mm glass
fiber filter disk. The disks were dried and placed on the agar surface
1.5 cm from the plug of inoculum. Plates were incubated at room
temperature, radial growth was measured, and hyphal growth and
morphology were assessed microscopically.
Zoospore Lysis
A zoospore suspension (40 ml) of Phytophthora ramorum Pr-102 (ob-
tained from Niklaus Grunwald, USDA-ARS; Corvallis, OR) was placed53–63, January 2007 ª2007 Elsevier Ltd All rights reserved 61
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orfamide A to a final concentration of 0.0, 7.8, 15.6, 31.3, 62.5, or
125.0 mg/ml. There were three replicate slides for each orfamide A
concentration. Immediately after mixing, suspensions were observed
under a stereomicroscope, and a timed measurement was taken for
immobilization and lysis of the zoospores. The experiment was con-
ducted twice with essentially identical results.
Supplemental Data
General analytical instrumentation and methods as well as tables de-
tailing the bioinformatical analysis; proof of transcription of the ofa
gene cluster; spectral data for the 1H-15N HMBC-guided isolation,
NMR, and MS spectral data; and amino acid analysis of orfamides
A–C (1–3), including structure elucidation for orfamides B (2) and C
(3), are available at http://www.chembiol.com/cgi/content/full/14/1/
53/DC1/.
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